JP4800687B2 - Antitumor agent and health food containing the same - Google Patents
Antitumor agent and health food containing the same Download PDFInfo
- Publication number
- JP4800687B2 JP4800687B2 JP2005195386A JP2005195386A JP4800687B2 JP 4800687 B2 JP4800687 B2 JP 4800687B2 JP 2005195386 A JP2005195386 A JP 2005195386A JP 2005195386 A JP2005195386 A JP 2005195386A JP 4800687 B2 JP4800687 B2 JP 4800687B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- bamboo
- hot water
- sample
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002246 antineoplastic agent Substances 0.000 title claims description 20
- 235000013402 health food Nutrition 0.000 title description 14
- 239000000284 extract Substances 0.000 claims description 79
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 52
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 52
- 241001330002 Bambuseae Species 0.000 claims description 52
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 52
- 239000011425 bamboo Substances 0.000 claims description 52
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000011436 cob Substances 0.000 claims description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 21
- 238000000605 extraction Methods 0.000 description 21
- 230000000259 anti-tumor effect Effects 0.000 description 17
- 239000000843 powder Substances 0.000 description 12
- 210000004881 tumor cell Anatomy 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 235000005911 diet Nutrition 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000221198 Basidiomycota Species 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 241000283984 Rodentia Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000000306 component Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000002601 intratumoral effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 241000222336 Ganoderma Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical group CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 2
- 206010039491 Sarcoma Diseases 0.000 description 2
- 208000006268 Sarcoma 180 Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- IVSZLXZYQVIEFR-UHFFFAOYSA-N m-xylene Chemical group CC1=CC=CC(C)=C1 IVSZLXZYQVIEFR-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 230000004565 tumor cell growth Effects 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- SPFMQWBKVUQXJV-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;hydrate Chemical compound O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O SPFMQWBKVUQXJV-BTVCFUMJSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 240000001080 Grifola frondosa Species 0.000 description 1
- 235000007710 Grifola frondosa Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000005827 Phyllostachys nigra Species 0.000 description 1
- 235000010717 Phyllostachys nigra Nutrition 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000012675 alcoholic extract Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229960004977 anhydrous lactose Drugs 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 229940062672 calcium dihydrogen phosphate Drugs 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229950008138 carmellose Drugs 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229940078552 o-xylene Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229940116317 potato starch Drugs 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 235000019814 powdered cellulose Nutrition 0.000 description 1
- 229920003124 powdered cellulose Polymers 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229960004029 silicic acid Drugs 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- -1 specifically Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、抗腫瘍剤及びそれを含む健康食品に係り、特に、経口投与、腫瘍細胞への直接投与の何れにおいても、著しい抗腫瘍効果を示す抗腫瘍剤と、そのような抗腫瘍剤を含んで、優れた抗腫瘍作用を発揮する、人の健康を維持するための健康食品に関するものである。 The present invention relates to an antitumor agent and a health food containing the antitumor agent, and in particular, an antitumor agent exhibiting a remarkable antitumor effect in both oral administration and direct administration to tumor cells, and such an antitumor agent. In addition, the present invention relates to a health food for maintaining human health, which exhibits excellent antitumor action.
従来から、サルノコシカケにて代表されるキノコ類には、腫瘍の他、糖尿病、高血圧、心臓病や肝臓病、更には、滋養強壮等の薬効があるとされて、漢方薬等として、広く用いられてきている。特に、その熱水抽出物は、経口摂取において、優れた抗腫瘍効果を示すことが明らかにされているが、腫瘍細胞に直接作用させた場合にあっては、その効果が低いことも認められている。 Traditionally, mushrooms represented by Sarnosh mushrooms have been widely used as traditional Chinese medicines because of their medicinal properties such as diabetes, hypertension, heart disease and liver disease, as well as nutritional tonic, in addition to tumors. ing. In particular, the hot water extract has been shown to have an excellent antitumor effect when taken orally, but it is also found to be less effective when directly acting on tumor cells. ing.
一方、本願出願人は、先に、特開2003−199530において、成長した竹やその若芽である筍等の竹類を、アルコール溶液で抽出して得られる竹の抽出物が、優れた抗腫瘍作用を有することを、明らかにした。而して、そのような竹の抽出物を有効成分とする抗腫瘍剤は、腫瘍細胞に直接作用させた場合(腫瘍内投与)において、著しい抗腫瘍作用を示すものではあるが、その経口摂取の場合において、ある程度の抗腫瘍効果を示すものの、その効果は今一つ充分ではないことが、明らかとなったのである。 On the other hand, the applicant of the present application previously described in Japanese Patent Application Laid-Open No. 2003-199530, an extract of bamboo obtained by extracting bamboo such as grown bamboo or its young shoots such as camellia with an alcohol solution is an excellent antitumor agent. It was clarified that it has an action. Thus, an anti-tumor agent comprising such bamboo extract as an active ingredient exhibits a marked anti-tumor effect when directly acting on tumor cells (intratumoral administration), but its oral intake In this case, it was revealed that although some antitumor effect was exhibited, the effect was not sufficient.
このように、従来から知られているサルノコシカケ等の熱水抽出物や竹の抽出物は、何れも、その抗腫瘍作用において、経口投与と腫瘍内投与の何れか一方において、その優れた効果を示すものであったのであり、その経口投与と腫瘍内投与の両方において、その優れた作用乃至は効果を発揮し得るものではなかったのである。 As described above, the hot water extract and bamboo extract, which are conventionally known, such as sarcoma moss, have an excellent effect in the antitumor action in either oral administration or intratumoral administration. In other words, both the oral administration and the intratumoral administration could not exert its excellent action or effect.
ここにおいて、本発明は、かかる事情を背景にして為されたものであって、その解決課題とするところは、経口投与及び腫瘍細胞への直接投与の何れにおいても著しい抗腫瘍効果を発揮し得る抗腫瘍剤、並びにそれを含む、人の健康の維持増進を補助する健康食品を提供することにある。 Here, the present invention has been made in the background of such circumstances, and the problem to be solved is that it can exhibit a remarkable antitumor effect in both oral administration and direct administration to tumor cells. An object of the present invention is to provide an antitumor agent and a health food containing the same, which assists in maintaining and improving human health.
そこで、本発明者等が、上記の課題を解決すべく、鋭意検討した結果、従来では単独にて使用されているサルノコシカケ乃至はキノコの熱水抽出物と、本願出願人が先に提案した竹の抽出物の作用に着目して、それら2種の抽出物を組み合わせ、共に、含有せしめることにより、抗腫瘍作用において、相乗的な向上効果が実現され得ると共に、その著しい抗腫瘍効果が、経口投与においても、また腫瘍細胞への直接投与においても、効果的に発揮され得ることが明らかとなったのである。 Thus, as a result of intensive studies by the present inventors to solve the above-mentioned problems, a hot water extract of sarno mushroom or mushroom that has been conventionally used alone and the bamboo previously proposed by the applicant of the present application. Focusing on the action of these extracts, combining these two kinds of extracts together allows a synergistic improvement effect in the antitumor action to be realized, and the remarkable antitumor effect is given orally. It became clear that it can be effectively exerted both in administration and in direct administration to tumor cells.
従って、本発明は、かかる知見に基づいて完成されたものであって、その要旨とするところは、竹のアルコール抽出物と、メシマコブの熱水抽出物の両者を、共に、有効成分として含有せしめたことを特徴とする抗腫瘍剤にある。
Therefore, the present invention has been completed based on such knowledge, and the gist thereof is that both an alcohol extract of bamboo and a hot water extract of Meshimakobu are included as active ingredients. An antitumor agent characterized by the above.
そして、本発明にあっては、前記竹のアルコール抽出物と前記メシマコブの熱水抽出物とは、有利には、2:8〜8:2の割合(重量比)において含有せしめられることとなる。
In the present invention, the bamboo alcohol extract and the hot water extract of Meshimakobu are advantageously contained in a ratio (weight ratio) of 2: 8 to 8: 2. .
また、本発明は、上述の如き抗腫瘍剤、具体的には、それを構成する竹のアルコール抽出物とメシマコブの熱水抽出物の両者を、健康食品構成成分として含有していることを特徴とする健康食品をも、その対象としているのである。
Further, the present invention is characterized in that the antitumor agent as described above, specifically, the bamboo alcohol extract and the hot water extract of Meshimakobu constituting it are contained as health food components. The health food is also the target.
このように、本発明に従う抗腫瘍剤にあっては、竹のアルコール抽出物と共に、メシマコブの熱水抽出物が、共に含有せしめられていることによって、それら両成分の相互作用に基づいて、優れた抗腫瘍効果を相乗的に発揮し得るものであり、また、経口投与及び腫瘍細胞への直接投与の何れの場合においても、著しい抗腫瘍効果を示し、以て、腫瘍の治療薬として有利に用いられ得るのである。
Thus, in the antitumor agent according to the present invention, together with the bamboo alcohol extract, the hot water extract of Meshima Cobb is contained together, so that it is excellent based on the interaction of these two components. The antitumor effect can be exerted synergistically, and it exhibits remarkable antitumor effect in both oral administration and direct administration to tumor cells, and is therefore advantageous as a therapeutic agent for tumors. It can be used.
また、本発明に従って、そのような抗腫瘍剤の成分、具体的には、竹のアルコール抽出物及びメシマコブの熱水抽出物の両者を、共に含有せしめてなる健康食品にあっては、それを日常的に経口摂取するようにすれば、腫瘍(癌)の進行を効果的に防いだり、或いは、その病巣の改善を効果的に図り得ることとなる。
In addition, according to the present invention, in a health food containing both components of such an antitumor agent, specifically, bamboo alcohol extract and hot water extract of Meshimakobu , If taken orally on a daily basis, the progression of the tumor (cancer) can be effectively prevented, or the lesion can be effectively improved.
ところで、かかる本発明において用いられる竹の抽出物は、一般に、よく知られている竹を原料として、それを、適当な抽出溶媒を用いて、通常の抽出操作手法に従って抽出して得られる抽出物であって、そこでは、原料としての竹は、例えば淡竹、真竹、孟宗竹、黒竹、矢竹、めだけ、バンブータリ(原産地:インドネシア)等が対象とされ、また、各種の竹を寄せ集めた雑竹であっても、何等差支えない。更に、成長した竹は勿論、その若芽である筍であってもよく、更に、使用する部位にあっても、稈、全草の何れであってもよいが、特に、真竹の稈の外周部が、特に好適に用いられることとなる。なお、竹は、筍を除いて、伐採後一年未満で、なるべく新鮮なものがよく、また筍の場合は、収穫後速やかに抽出処理するのが望ましい。但し、何れの場合も、新鮮なうちに冷凍保存すれば、長期間経過後も使用可能である。 By the way, the bamboo extract used in the present invention is generally an extract obtained by using a well-known bamboo as a raw material and extracting it according to a normal extraction procedure using an appropriate extraction solvent. However, the bamboo as the raw material is, for example, light bamboo, true bamboo, Munetake bamboo, black bamboo, Yatake, meme, bambutari (origin: Indonesia), etc. Even bamboo is acceptable. Furthermore, the grown bamboo may, of course, be a bud that is a young bud, and may be either a cocoon or whole plant, especially the outer periphery of a bamboo shoot. Is particularly preferably used. Bamboo should be fresh as much as possible, less than one year after harvesting, except for bamboo. In the case of bamboo, it is desirable to extract it immediately after harvesting. However, in any case, it can be used after a long period of time if it is stored frozen while it is fresh.
また、そのような竹を抽出する抽出溶媒としては、アセトン、ヘプタン、ヘキサン、シクロヘキサン、四塩化炭素、クロロホルム、ジクロロメタン、酢酸メチル、酢酸エチル、酢酸ブチル、アセトニトリル、グリセリン、トルエン、ジエチルエーテル、石油エーテル、o−キシレン、m−キシレン、p−キシレン、1−ブタノール、t−ブタノール、1−プロパノール、2−プロパノール、メタノール等、油溶性物質を抽出する有機溶媒が好適に用いられ、そして、そのような溶媒により抽出して得られる油溶性抽出物、中でも、アセトンを抽出溶媒として得られた抽出物(アセトン抽出物)が、特に腫瘍細胞の増殖を著しく抑制し得るものとして、有利に用いられることとなる。 As an extraction solvent for extracting such bamboo, acetone, heptane, hexane, cyclohexane, carbon tetrachloride, chloroform, dichloromethane, methyl acetate, ethyl acetate, butyl acetate, acetonitrile, glycerin, toluene, diethyl ether, petroleum ether Organic solvents for extracting oil-soluble substances, such as o-xylene, m-xylene, p-xylene, 1-butanol, t-butanol, 1-propanol, 2-propanol, methanol, etc. are preferably used, and so on Oil-soluble extract obtained by extraction with a suitable solvent, especially an extract obtained by using acetone as an extraction solvent (acetone extract) should be advantageously used particularly as it can remarkably suppress the growth of tumor cells. It becomes.
なお、竹の抽出溶媒としては、上記で例示したものの他、本発明者等が先の出願において明らかにした、エタノールの如きアルコールやその水溶液、例えば、アルコール濃度が50〜70%程度のアルコール水溶液を用いることも可能であり、それによって得られる竹のアルコール抽出物も、本発明においては、使用可能である。 As the bamboo extraction solvent, in addition to those exemplified above, alcohols such as ethanol and aqueous solutions thereof, for example, alcohol aqueous solutions having an alcohol concentration of about 50 to 70%, which were clarified in the previous application by the present inventors, etc. Can be used, and bamboo alcohol extract obtained thereby can also be used in the present invention.
そして、かかる抽出溶媒を用いた竹の抽出操作は、従来の抽出操作と同様にして行われ得るものであって、例えば、先ず、原料となる竹を水洗いし、異物を除去した後、粉砕して、最終的に3〜5mm程度の大きさ、又は10mm径程度のスクリーンを通過する程度の大きさとされる。次いで、そのような大きさの粉砕物を、上述の如き抽出溶媒に浸漬して、その抽出が行われるのであるが、その浸漬は、溶液中に充分に色が出るまで継続される。その期間は、常温下で、一般に、約6ヶ月程度が目安となるが、それは、抽出溶媒毎に異なり、また、加熱した場合にあっては、その抽出時間を短縮せしめることが出来、例えば、1〜2時間程度の浸漬・抽出時間において、充分な抽出物を得ることも可能であるが、また、これも、抽出溶媒毎に、抽出に有効な時間乃至は期間が、適宜に決定されることとなる。 The extraction operation of bamboo using such an extraction solvent can be performed in the same manner as the conventional extraction operation. For example, first, bamboo as a raw material is washed with water to remove foreign substances, and then pulverized. The final size is about 3 to 5 mm, or the size that passes through a screen having a diameter of about 10 mm. Then, the pulverized product having such a size is immersed in an extraction solvent as described above, and the extraction is performed. The immersion is continued until a sufficient color appears in the solution. The period is generally about 6 months at room temperature, but it is different for each extraction solvent, and when heated, the extraction time can be shortened, for example, It is possible to obtain a sufficient extract in the immersion / extraction time of about 1 to 2 hours, but this also determines the time or period effective for extraction for each extraction solvent. It will be.
次いで、この得られた抽出液は、遠心分離機にて固液分離され、その液相が、回収されて、濃縮された後、その濃縮した竹抽出物に、固形分で等量の賦形剤を加えて、フリーズドライ手法にて乾燥せしめられ、目的とする竹抽出物が、粉末として取り出されることとなるのである。 Subsequently, the obtained extract is subjected to solid-liquid separation in a centrifuge, and the liquid phase is recovered and concentrated, and then the concentrated bamboo extract is shaped with an equal amount of solid content. The agent is added and dried by freeze drying, and the target bamboo extract is taken out as a powder.
なお、ここで、そのような竹抽出物を粉末化するために用いられる賦形剤としては、公知の何れのものをも、適宜に選択して用いられ得るものであって、例えば、カオリン、タルク、軽質無水ケイ酸、小麦デンプン、米デンプン、結晶セルロース、粉末セルロース、デキストリン、乳糖、無水乳糖、馬鈴薯デンプン、リン酸水素カルシウム、無水リン酸水素カルシウム、リン酸二水素カルシウム、オキシセル(酸化セルロース)、果糖、カルメロース、キシリトール、D−ソルビトール、低置換度ヒドロキシプロピルセルロース、トウモロコシデンプン、白糖、精製白糖、ヒドロキシプロピルセルロース、ポビドン、D−マンニトール、アルファー化デンプン、クロスポビドン、結晶セルロース・カルメロースナトリウム、結晶セルロース(粒)、ヒドロキシプロピルスターチ、ブドウ糖水和物、部分アルファー化デンプン、粉末還元麦芽糖水飴等を例示することが出来る。 Here, as the excipient used to powder such bamboo extract, any known one can be appropriately selected and used, for example, kaolin, Talc, light anhydrous silicic acid, wheat starch, rice starch, crystalline cellulose, powdered cellulose, dextrin, lactose, anhydrous lactose, potato starch, calcium hydrogen phosphate, anhydrous calcium hydrogen phosphate, calcium dihydrogen phosphate, oxycell (cellulose oxide ), Fructose, carmellose, xylitol, D-sorbitol, low substituted hydroxypropylcellulose, corn starch, sucrose, purified sucrose, hydroxypropylcellulose, povidone, D-mannitol, pregelatinized starch, crospovidone, crystalline cellulose carmellose sodium , Crystalline cellulose ( ), Hydroxypropyl starch, glucose hydrate, partially pregelatinized starch, can be exemplified a powder hydrogenated maltose starch syrup and the like.
一方、本発明に従って、上述の如き竹抽出物と組み合わされて、共に用いられるサルノコシカケ乃至はキノコの熱水抽出物は、それら抽出対象とされるサルノコシカケやキノコに対して、通常の熱水による抽出操作を施して得られるものであって、キノコとしては、例えば、アガリスク、マイタケ、ハナビラタケ、ヤマブシタケ、シイタケ等の真菌に属する担子菌類及び子嚢菌類を主とする子実体を形成するものであり、菌糸体若しくは子実体又はその一部が用いられる。また、メシマコブ、レイシ、鹿角レイシ、コフキタケ、チャーガ、カワラタケ等、担子菌類の多孔菌科やキコブタケ科のうちの、質の硬い多年生のもの、所謂サルノコシカケも対象とされ、その外周部、内部、全体の何れをも原料として用いて、熱水抽出される。 On the other hand, in accordance with the present invention, the hot water extract of sarcoma or mushrooms used in combination with the bamboo extract as described above is extracted with normal hot water for the sorghum and mushrooms to be extracted. It is obtained by performing an operation, and as a mushroom, for example, it forms a fruiting body mainly composed of basidiomycetes and ascomycetes belonging to fungi such as agarisk, maitake, hanabiratake, yamabushitake, shiitake, A mycelium or fruit body or a part thereof is used. In addition, the peripheries and so-called Sarnokoshika of the hard perennials of basidiomycete of the basidiomycetes such as Mesima Kobu, Ganoderma, Ganoderma radish, Kofukitake, Chaga, Kawaratake, etc. Either of these is used as a raw material and is extracted with hot water.
なお、かかる熱水抽出操作は、具体的には、例えば、サルノコシカケやキノコを粉砕して、3〜5mm角程度の大きさとした後、水を加えて、1〜10時間程度、加熱抽出することにより、抽出液が形成され、その後、遠心分離機にて固液分離した後、液相の抽出液が、濃縮される。その際、加熱抽出時間は、原料(サルノコシカケ等のキノコ)の種類や加熱温度、更には、目的とする抽出成分の濃度等に応じて、適宜に選定されることとなる。そして、前記した濃縮操作にて濃縮された抽出液には、更に、その固形分に等量の、前記例示の如き賦形剤が添加され、更に、噴霧乾燥手法等に従って粉末化されて、用いられることとなるのである。 In addition, the hot water extraction operation specifically includes, for example, crushing sarcophagus mushrooms and mushrooms to a size of about 3 to 5 mm square, and then adding water to perform heat extraction for about 1 to 10 hours. As a result, an extract is formed, and after solid-liquid separation with a centrifuge, the liquid-phase extract is concentrated. At that time, the heating extraction time is appropriately selected according to the type of raw material (mushrooms such as Sarno mushrooms), the heating temperature, and the concentration of the target extraction component. Further, the extract liquid concentrated by the above-described concentration operation is further added with the same amount of excipients as exemplified above in the solid content, and further powdered according to the spray drying method and the like. It will be done.
そして、かくの如くして得られる竹抽出物(粉末)とサルノコシカケ乃至はキノコの熱水抽出物(粉末)とを混合することにより、本発明に従う抗腫瘍剤や、それを含む健康食品を得ることが出来るのであるが、その際、竹の抽出物とサルノコシカケ乃至はキノコの熱水抽出物の混合割合は、目的に応じて、適宜に決定され、特に限定されるものではないが、一般に、竹抽出物:サルノコシカケ/キノコ熱水抽出物は、重量比にて、2:8〜8:2の範囲内において決定されることとなる。 And the antitumor agent according to this invention and the health food containing the same are obtained by mixing the bamboo extract (powder) obtained in this way and the hot water extract (powder) of Sarno mushroom or mushroom. In this case, the mixing ratio of the bamboo extract and the hot water extract of the moss mushroom or mushroom is appropriately determined according to the purpose and is not particularly limited. Bamboo extract: Sarno mushroom / mushroom hot water extract will be determined in the range of 2: 8-8: 2 by weight ratio.
また、本発明にあっては、上記した竹の抽出物とサルノコシカケ乃至はキノコの熱水抽出物の両者を混合して得られる混合物を用いて、或いは、それら抽出物を順次配合せしめることによって、それら2種の抽出物が共存せしめられてなる抗腫瘍剤や健康食品が形成されることとなるのであるが、それら抗腫瘍剤や健康食品の形態としては、固形、粉末、顆粒、液体等の適宜の形態が、目的に応じて選択されることとなる。例えば、抗腫瘍剤を注射薬とする場合にあっては、液体形態において、従来からの注射薬と同様にして調製されることとなるのである。また、健康食品とする場合にあっては、竹の抽出物やサルノコシカケ乃至はキノコの熱水抽出物が、そのまま用いられる他、それら抽出物が、食品材料に添加、配合されたり、デンプンやビタミン等の他の成分と配合されたりして、目的とする形態の健康食品に仕上げられることとなる。 Moreover, in the present invention, by using a mixture obtained by mixing both the bamboo extract and the hot water extract of sarno mushroom or mushroom, or by sequentially blending these extracts, The anti-tumor agent and health food formed by the coexistence of these two types of extracts will form, but the forms of these anti-tumor agent and health food include solids, powders, granules, liquids, etc. An appropriate form is selected according to the purpose. For example, when an antitumor agent is used as an injection, it is prepared in a liquid form in the same manner as a conventional injection. In addition, in the case of health foods, bamboo extract and hot water extract of sarcophagus or mushroom can be used as they are, and these extracts can be added to and blended with food ingredients, starch and vitamins. Or the like and other ingredients, and finished into a desired form of health food.
また、かかる本発明に従う抗腫瘍剤やそれを含む健康食品の服用量や摂取量としては、特別な限定はないものの、一般に、一日あたり、大人で200〜600mg/人程度である。 In addition, the dose and intake of the antitumor agent according to the present invention and health food containing the same are generally about 200 to 600 mg / person for adults per day, although there is no particular limitation.
以下に、本発明の実施例を示し、本発明を更に具体的に明らかにすることとするが、本発明が、そのような実施例の記載によって、何等の制約をも受けるものでないことは、言うまでもないところである。また、本発明には、以下の実施例の他にも、更には、上記した具体的記述以外にも、本発明の趣旨を逸脱しない限りにおいて、当業者の知識に基づいて、種々なる変更、修正、改良等を加え得るものであることが、理解されるべきである。なお、以下の実施例において、特に断りのない限り、部や比、百分率は、何れも重量基準にて示されている。 Examples of the present invention will be shown below to clarify the present invention more specifically. However, the present invention is not limited by the description of such examples. Needless to say. In addition to the following examples, the present invention includes various modifications based on the knowledge of those skilled in the art without departing from the spirit of the present invention, in addition to the specific description described above. It should be understood that modifications, improvements, etc. can be made. In the following examples, all parts, ratios and percentages are shown on a weight basis unless otherwise specified.
実施例 1
真竹を水洗いして、異物を除去した後、粉砕し、最終的に3〜5mmの粉砕物とした。そして、その粉砕物に10倍量の60%アルコール水溶液を加え、約60℃の温度において2時間加熱することにより、抽出操作を、実施した、次いで、この加熱抽出操作の後、遠心分離機にて固液分離することにより、アルコール抽出液を得て、更にそれを濃縮した後、固形分等量の賦形剤(シクロデキストリン)を加えて、フリーズドライ手法にて乾燥せしめることにより、竹のアルコール抽出物の粉末を得た。
Example 1
The bamboo was washed with water to remove foreign substances and then pulverized to finally obtain a pulverized product of 3 to 5 mm. Then, 10 times the amount of 60% alcohol aqueous solution was added to the pulverized product, and the extraction operation was performed by heating at a temperature of about 60 ° C. for 2 hours. By separating the solution into solid and liquid, an alcoholic extract is obtained, further concentrated, added with an equal amount of excipient (cyclodextrin), and dried by freeze-drying. An alcohol extract powder was obtained.
一方、メシマコブ(サルノコシカケ)を用い、それを粉砕することにより、5mm以下の大きさのメシマコブ粉砕物とした。そして、その粉砕物に対して、10倍量の精製水を加え、16時間浸漬保持した後、80℃の温度で4時間抽出操作を実施し、その後、濾過濃縮した後、固形分等量の賦形剤(シクロデキストリン)を加えて、噴霧乾燥することにより、メシマコブ熱水抽出物の粉末を得た。 On the other hand, mesimacob (Sarnokoshikake) was used and pulverized to obtain pulverized mesimacob having a size of 5 mm or less. Then, 10 times the amount of purified water is added to the pulverized product, and after immersion for 16 hours, the extraction operation is carried out at a temperature of 80 ° C. for 4 hours, and then concentrated by filtration. An excipient (cyclodextrin) was added and spray-dried to obtain a powder of Meshimakobu hot water extract.
そして、本発明品の経口投与による抗腫瘍効果を確認するために、上記調製された竹アルコール抽出物及びメシマコブ熱水抽出物を用い、次の試料1〜4を、マウス飼育飼料として、調製した。なお、試料1は、竹アルコール抽出物配合飼料であって、マウスの通常飼料:ラボラトリーローデントダイエット(日本SLC株式会社製品)に、竹アルコール抽出物を1%の割合において混合したものであり、試料2は、メシマコブ熱水抽出物配合飼料であって、上記のラボラトリーローデントダイエットにメシマコブ熱水抽出物を1%の割合で混合せしめたものである。また、試料3は、本発明品配合飼料であって、上記の竹アルコール抽出物及びメシマコブ熱水抽出物を1:1の割合で混合せしめ、その混合物(本発明品)を、上記した通常飼料(ラボラトリーローデントダイエット)に1%の割合において混合せしめたものである。なお、試料4は、コントロールであって、前記した抽出物が全く配合されていない通常飼料(ラボラトリーローデントダイエット)のみのものである。
And in order to confirm the antitumor effect by oral administration of this invention product, the following samples 1-4 were prepared as a mouse breeding feed using the bamboo alcohol extract and Meshimakobu hot water extract which were prepared above. . Sample 1 is a bamboo alcohol extract blended feed, which is obtained by mixing bamboo alcohol extract in a proportion of 1% with normal feed for mice: laboratory low dent diet (product of Japan SLC Co., Ltd.),
そして、マウス実験においては、5週齢の雄性ICRマウス(日本SLC株式会社)を用い、それを、1週間通常飼料(ラボラトリーローデントダイエット)にて予備飼育した後、その右下腹部皮下に腹水癌細胞( sarcoma-180 )の2.0×106 cells/head を移植して、飼育を行なった。なお、動物飼育室条件としては、実験期間を通じて、恒温(24℃±1℃)で、明暗周期を12時間(明周期:6時〜18時)とした。 In the mouse experiment, a 5-week-old male ICR mouse (Japan SLC Co., Ltd.) was used, which was preliminarily raised for 1 week with a normal diet (laboratory rodent diet), and then ascites was subcutaneously injected into the right lower abdomen. 2.0 × 10 6 cells / head of cancer cells (sarcoma-180) were transplanted and reared. The animal breeding room conditions were constant temperature (24 ° C. ± 1 ° C.) and the light / dark cycle was 12 hours (bright cycle: 6 o'clock to 18 o'clock) throughout the experiment.
そして、かかる移植の2週間後、各群10匹に群分けした。更に、この群分けの後、各群のマウスには、先に調製した試料1〜4のいずれかを、28日間自由摂取させた。各マウスの腫瘍面積は、ノギスにより、2,3日毎に長径と短径を計測し、その積により求めた。 Then, 2 weeks after the transplantation, each group was divided into 10 animals. Further, after this grouping, each group of mice was allowed to freely take any of the previously prepared samples 1 to 4 for 28 days. The tumor area of each mouse was determined by measuring the major and minor diameters every few days with calipers and multiplying them.
このようにして得られた試料1〜4の摂取による腫瘍面積の結果を、図1に示すが、それより明らかな如く、本発明品を配合した飼料(試料3)を与えた群は、通常食(試料4)を与えた場合は勿論のこと、竹アルコール抽出物やメシマコブ熱水抽出物を、それぞれ単独で配合した飼料(試料1及び試料2)を摂取した群よりも、その腫瘍面積の拡大が効果的に抑制されているのであり、このことよりしても、本発明品が、優れた抗腫瘍効果を発揮することが確認されるのである。 The results of the tumor area resulting from the ingestion of Samples 1 to 4 obtained in this way are shown in FIG. 1. As is clear from this, the group to which the feed containing the product of the present invention (Sample 3) was given is usually Of course, when the diet (sample 4) was given, the tumor area was higher than the group that ingested the feed (sample 1 and sample 2) each containing the bamboo alcohol extract or the hot water extract of Mishima Kob alone. The expansion is effectively suppressed, and even from this, it is confirmed that the product of the present invention exhibits an excellent antitumor effect.
実施例 2
実施例1において調製した竹抽出物粉末及びメシマコブ熱水抽出物粉末を用い、それぞれ精製水に溶解して、水溶液とすることにより、竹抽出物液(試料5)及びメシマコブ熱水抽出物液(試料6)を調製した。また、それら竹抽出物粉末及びメシマコブ熱水抽出物粉末を1:1の割合で混合して、本発明品とし、それを精製水に溶解して、水溶液とすることにより、本発明品の水溶液(試料7)を調製した。
Example 2
Bamboo extract powder (sample 5) and Messimacob hot water extract liquid (sample 5) and Messimacob hot water extract liquid (sample 5) and bamboo shoot powder prepared in Example 1 were dissolved in purified water to form aqueous solutions. Sample 6) was prepared. In addition, the bamboo extract powder and Messimacob hot water extract powder are mixed at a ratio of 1: 1 to obtain the product of the present invention, which is dissolved in purified water to obtain an aqueous solution. (Sample 7) was prepared.
そして、本発明品の腫瘍細胞に対する直接的な抗腫瘍効果を確認するために、上記で調製された試料5〜7を、それぞれ滅菌濾過し、最終濃度で各抽出物又はその混合物である本発明品の固形分が100又は200μg/mLとなるように、EME・M培地(10%FBS)(大日本製薬株式会社)に添加した。次いで、96穴マイクロプレートに、各検体入り培地と腹水癌細胞( sarcoma-180 )の2.5×103 cells/well ずつ分注して、炭酸ガス・インキュベータ内において、48時間培養した。更に、かかる培養の後、セル・カウンティング・キット(Cell Counting Kit )−8(株式会社同仁化学研究所製)を各ウェルに10μLずつ添加し、そして、炭酸ガス・インキュベータ内において、4時間呈色反応を行なった。この呈色反応の後、マイクロレートリーダを用い、450nmの吸光度を測定して、それぞれの試料の各濃度における腫瘍細胞の増殖抑制率(%)を求めた。そして、その結果を、図2に示す。 And in order to confirm the direct anti-tumor effect with respect to the tumor cell of this invention product, each sample 5-7 prepared above is each sterilized-filtered, and this invention which is each extract or its mixture by final concentration. The product was added to EME · M medium (10% FBS) (Dainippon Pharmaceutical Co., Ltd.) so that the solid content of the product was 100 or 200 μg / mL. Next, 2.5 × 10 3 cells / well of each sample-containing medium and ascites tumor cells (sarcoma-180) were dispensed into a 96-well microplate and cultured in a carbon dioxide incubator for 48 hours. Further, after such culturing, 10 μL of Cell Counting Kit-8 (manufactured by Dojindo Laboratories Co., Ltd.) is added to each well, and coloring is performed for 4 hours in a carbon dioxide incubator. Reaction was performed. After this color reaction, absorbance at 450 nm was measured using a microrate reader, and the growth inhibition rate (%) of tumor cells at each concentration of each sample was determined. The result is shown in FIG.
かかる図2に示される各試料の腫瘍細胞増殖抑制率において、本発明品が200μg/mL添加された試料7(200μg/mL)、竹抽出物が100μg/mL添加された試料5a(100μg/mL)、メシマコブ熱水抽出物が100μg/mL添加された試料6a(100μg/mL)の抑制率は、それぞれ、97.5%、92.2%、50.3%であり、それら試料5aと試料6aを混合した形態となる試料7aとすることにより、腫瘍細胞の増殖に対する抑制効果が効果的に高められ得ることが、理解されるのである。また、かかる試料7(200μg/mL)と竹抽出物を200μg/mL配合した試料5b(200μg/mL)、メシマコブ熱水抽出物を200μg/mL配合した試料6b(200μg/mL)を比較しても、それら竹抽出物とメシマコブ熱水抽出物を組み合わせて配合した本発明品を用いることによって、それら抽出物が有する抗腫瘍効果が相乗的に増強されていることも認めることが出来る。 In the tumor cell growth inhibition rate of each sample shown in FIG. 2, sample 7 (200 μg / mL) to which the product of the present invention was added 200 μg / mL, sample 5a (100 μg / mL) to which bamboo extract was added 100 μg / mL. ), And the inhibition rate of Sample 6a (100 μg / mL) to which 100 μg / mL of the Meshimakobu hot water extract was added was 97.5%, 92.2%, and 50.3%, respectively. It is understood that the inhibitory effect on the growth of tumor cells can be effectively enhanced by using the sample 7a in a mixed form of 6a. In addition, the sample 7 (200 μg / mL) was compared with the sample 5b (200 μg / mL) containing 200 μg / mL bamboo extract and the sample 6b (200 μg / mL) containing 200 μg / mL hot water extract. Moreover, it can also be recognized that the antitumor effect of these extracts is synergistically enhanced by using the present invention compounded by combining the bamboo extract and the hot water extract of Meshimakobu.
そして、上記した実施例1及び実施例2の結果より、本発明品においては、サルノコシカケ乃至はキノコの抽出物と竹抽出物を混合することにより、経口摂取によって優れた抗腫瘍効果を発揮すると同時に、細胞に直接作用させても、強い抗腫瘍作用を有していることが明らかとなったのであり、従って、本発明品は、健康食品又は経口用抗腫瘍剤としてのみならず、注射薬等のように、直接患部に作用させることにより、癌の進行を阻止したり、或いは改善させ得る効果を奏し得るのである。 And from the result of above-mentioned Example 1 and Example 2, in the product of the present invention, an antitumor effect is exhibited by oral ingestion by mixing an extract of sarcophagus or mushroom and a bamboo extract. Therefore, it was revealed that even when directly acting on cells, it has a strong antitumor effect, and therefore the product of the present invention is not only used as a health food or an oral antitumor agent, but also as an injection. As described above, by directly acting on the affected area, the effect of preventing or improving the progression of cancer can be obtained.
Claims (2)
The antitumor agent according to claim 1, wherein the bamboo alcohol extract and the hot water extract of Meshimakobu are contained in a weight ratio of 2: 8 to 8: 2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005195386A JP4800687B2 (en) | 2005-07-04 | 2005-07-04 | Antitumor agent and health food containing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005195386A JP4800687B2 (en) | 2005-07-04 | 2005-07-04 | Antitumor agent and health food containing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007008905A JP2007008905A (en) | 2007-01-18 |
JP4800687B2 true JP4800687B2 (en) | 2011-10-26 |
Family
ID=37747854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005195386A Active JP4800687B2 (en) | 2005-07-04 | 2005-07-04 | Antitumor agent and health food containing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4800687B2 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0576320A (en) * | 1991-09-24 | 1993-03-30 | Kanazawa Nishiki:Kk | Daily dishes |
JP4080296B2 (en) * | 2001-10-24 | 2008-04-23 | アダプトゲン製薬株式会社 | Antitumor agent |
-
2005
- 2005-07-04 JP JP2005195386A patent/JP4800687B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2007008905A (en) | 2007-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2412377B1 (en) | Burdock fruit extract containing arctigenin at high content and process for producing same | |
EP2682122A1 (en) | Growth hormone secretion promoter | |
JP3768795B2 (en) | Xanthine oxidase inhibitor | |
KR20170121866A (en) | Extract of cordyceps militaris, manufacturing method of the same, and composition comprising cordycepin isolated thereform for the prevent or treatment of lung cancer | |
KR101567573B1 (en) | Composition comprising extracts of Codonopsis lanceolata or compounds isolated therefrom for preventing, improving or treating obesity or obesity-related disease | |
JP2008260695A (en) | Hepatopathy inhibitor | |
US9174925B2 (en) | Phorbol type diterpene compound, pharmaceutical composition for treatment or prevention of viral infectious diseases including same | |
KR101557934B1 (en) | Composition comprising extracts of Codonopsis lanceolata or compounds isolated therefrom for preventing, improving or treating obesity or obesity-related disease | |
JP4800687B2 (en) | Antitumor agent and health food containing the same | |
KR101692889B1 (en) | Composition comprising an extract or a fraction of Daphne kamtschatica for preventing or treating inflammatory diseases | |
KR102150114B1 (en) | Composition for preventing, improving or treating arthritis comprising extract of Ganoderma lucidum, extract of Carthamus tinctorius L. seeds or mixture thereof | |
KR102092729B1 (en) | Pharmaceutical composition for preventing or treating liver damage comprising Curcuma longa extract | |
KR101954891B1 (en) | A composition for treating or improving hepatic fibrosis comprising Seahorse extract | |
JP2006016340A (en) | Blood uric acid level reduction agent having extract of punica granatum l. as active ingredient | |
KR101724587B1 (en) | Composition for treating, improving or preventing liver injury and liver dysfunction | |
JPH11302191A (en) | Immunoactivator and antitumor agent containing extract from lyophyllum decastes (fr.) sing. as active ingredient | |
JP2006036787A (en) | Xanthine oxidase inhibitor | |
KR101794924B1 (en) | Method for Isolating Isorhamnetin for Prevention or Treatment of Non-alcoholic Fatty Liver Disease derived from Salicornia SPP. | |
KR20150085215A (en) | Composition comprising black garlic and Gastrodia elata extract with antioxidant activity and method of making the same | |
US11623910B1 (en) | Compound isolated from Torilidis fructus, and anticancer pharmaceutical composition containing same as active ingredient | |
KR102069125B1 (en) | Pharmaceutical composition for preventing or treating liver damage comprising Curcuma longa extract | |
JP4104853B2 (en) | Liver function protecting or improving agent | |
KR102143243B1 (en) | Composition for preventing, improving or treating arthritis comprising extract of Ganoderma lucidum, extract of Cirsium japonicum or mixture thereof | |
CN108185245A (en) | A kind of preparation method of ginseng dish's soy drink | |
WO2000032214A1 (en) | Preventives for hepatopathy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070601 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100921 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101122 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110111 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110207 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110802 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110804 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140812 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4800687 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |